Post date May 12, 2023 Experience Black Spade Acquisition $23 billion combination with VinFast We are advising Black Spade on its de-SPAC transaction
Post date January 17, 2023 Experience China Resources Beer RMB12.3 billion acquisition of Jinsha Winery We advised China Resources Beer on the acquisition of a controlling interest in Jinsha Winery
Post date January 11, 2023 Experience Sirio Pharma acquisition of a majority stake of Best Formulations We advised Sirio Pharma on the acquisition
Post date September 8, 2022 Experience Tencent €300 million investment in Ubisoft We are advising Tencent on the transaction
Post date August 19, 2022 Experience Esco Aster spinoff transactions We are advising Esco Lifesciences on the spinoff
Post date August 11, 2022 Experience InSilico Medicine $35 million Series D2 financing We are advising InSilico Medicine on the financing
Post date August 3, 2022 Experience Taibang Biologic Group $300 million equity raising We are advising Taibang Biologic Group in connection with its equity raising by a group of investors
Post date June 29, 2022 Experience Tencent renewed strategic cooperation with JD.com We are advising Tencent on the renewal of the strategic cooperation agreement and purchase of ordinary shares of JD.com
Post date June 7, 2022 Experience InSilico Medicine $60 million Series D financing We are advising InSilico Medicine in connection with its $60 million Series D financing
Post date March 23, 2022 Experience Jeeves $180 million Series C equity financing round We advised Tencent as lead investor in the new round